{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:37Z","timestamp":1786119577002,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/inf.0b013e31821146f7","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T03:23:51Z","timestamp":1298431431000},"page":"651-655","source":"Crossref","is-referenced-by-count":38,"title":["CARESS: The Canadian Registry of Palivizumab"],"prefix":"10.1097","volume":"30","author":[{"given":"Ian","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosco A.","family":"Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/jinf.2001.1016","article-title":"Respiratory syncytial virus infections in children and adults.","volume":"45","author":"Collins","year":"2002","journal-title":"J Infect"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"R3-6-20210202","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus.","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus.","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.inf.0000232632.86800.8c","article-title":"Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children.","volume":"25","author":"Schanzer","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1542\/peds.99.3.e9","article-title":"PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease.","volume":"99","author":"Wang","year":"1997","journal-title":"Pediatrics"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3476(05)90000-0","article-title":"Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada.","volume":"121","author":"Navas","year":"1992","journal-title":"J Pediatr"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among US children, 1980\u20131996.","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s100960100527","article-title":"Incidence of respiratory syncytial virus-positive hospitalizations in Germany.","volume":"20","author":"Weigl","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ppul.10047","article-title":"Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.","volume":"33","author":"Lanari","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-3038.2005.00298.x","article-title":"Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.","volume":"16","author":"Henderson","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"issue":"suppl 1","key":"R13-6-20210202","first-page":"S26","article-title":"Immunoprophylaxis of respiratory syncytial virus: global experience.","volume":"3","author":"Simoes","year":"2002","journal-title":"Respir Res"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.","volume":"176","author":"Johnson","year":"1997","journal-title":"J Infect Dis"},{"issue":"suppl B","key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1053\/rmed.2002.1298","article-title":"Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants.","volume":"96","author":"Young","year":"2002","journal-title":"Respir Med"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1651-2227.2003.tb00533.x","article-title":"Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark.","volume":"92","author":"Pedersen","year":"2003","journal-title":"Acta Paediatr"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00431-007-0426-y","article-title":"Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database.","volume":"166","author":"Simon","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ppul.10175","article-title":"Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.","volume":"34","author":"Lacaze-Masmonteil","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/jp.2008.28","article-title":"Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.","volume":"28","author":"Frogel","year":"2008","journal-title":"J Perinatol"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00006454-200206000-00007","article-title":"Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.","volume":"21","author":"Oh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R24-6-20210202","first-page":"1","article-title":"Statement on the recommended use of monoclonal anti-RSV antibody (palivizumab).","volume":"29","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: policy statements\u2014modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.","volume":"124","year":"2009","journal-title":"Pediatrics"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/pch\/8.10.631","article-title":"Use of palivizumab in children without congenital heart disease.","volume":"8","author":"Langley","year":"2003","journal-title":"Paediatr Child Health"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/pch\/14.8.521","article-title":"Prevention of respiratory syncytial virus infection.","volume":"14","author":"Samson","year":"2009","journal-title":"Paediatr Child Health"},{"issue":"suppl B","key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/rmed.2002.1294","article-title":"An update on respiratory syncytial virus epidemiology: a developed country perspective.","volume":"96","author":"Law","year":"2002","journal-title":"Respir Med"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1526-0542(02)00306-8","article-title":"Current strategies in the prevention of respiratory syncytial virus disease.","volume":"4","author":"Paes","year":"2003","journal-title":"Paediatr Respir Rev"},{"key":"R30-6-20210202","article-title":"Quarterly demographic estimates: July to September 2009. Catalogue number 91-002-X.","year":"2009"},{"key":"R31-6-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0b013e3181b34e52","article-title":"High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection.","volume":"29","author":"Bloemers","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.prrv.2009.06.003","article-title":"Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes.","volume":"10","author":"Resch","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.2008.139188","article-title":"Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.","volume":"94","author":"Thorburn","year":"2009","journal-title":"Arch Dis Child"},{"key":"R34-6-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/INF.0b013e31805d01e3","article-title":"Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.","volume":"26","author":"Wilkesmann","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R35-6-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006454-200109000-00010","article-title":"Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.","volume":"20","author":"Carbonell-Estrany","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R36-6-20210202","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00006454-200007000-00002","article-title":"Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.","volume":"19","author":"Carbonell-Estrany","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R37-6-20210202","first-page":"806","article-title":"Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis.","volume":"140","author":"McConnochie","year":"1986","journal-title":"Am J Dis Child"},{"key":"R38-6-20210202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1007658411953","article-title":"The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis.","volume":"16","author":"Gurkan","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"R39-6-20210202","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1067\/S0022-3476(03)00511-0","article-title":"Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease.","volume":"143","author":"Simoes","year":"2003","journal-title":"J Pediatr"},{"key":"R40-6-20210202","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.inf.0000053885.34703.84","article-title":"Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.","volume":"22","author":"Romero","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R41-6-20210202","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","article-title":"Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.","volume":"22","author":"Pedraz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R42-6-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004310050798","article-title":"International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.","volume":"157","author":"Behrendt","year":"1998","journal-title":"Eur J Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31821146f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:54:11Z","timestamp":1786042451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201108000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31821146f7","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}